News

Zymeworks has announced that it has entered into a new licensing agreement with GSK for the research, development, and commercialization of novel bi-specific antibodies enabled using Zymeworks’ Azymetric™ drug discovery platform.

Evotec and ex scientia announce partnership to discover bispecific small molecule immuno-oncology therapeutics.

Queen’s University Belfast and Domainex win late-stage award to progress novel lung cancer drug candidate into the clinic.

Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.

An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.

A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.

HMS researchers have discovered two ways a compound blocks dengue virus.

Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.

A rational drug engineering approach could breathe new life into drug development.

Plasticell is pleased to announce it has been awarded the 2016 Queen’s Award for Enterprise in Innovation.